Peter Crane is co-founder and CEO of Caeruleus, a tech-enabled biotech company he spun out of Oxford's Medical Sciences Division in late 2022. The company combines foundational work in single-cell long-read sequencing with machine learning to develop differentiated therapies across a range of chronic and rare diseases. He has spoken about what it takes to nurture founder-driven ventures within the Oxford ecosystem.

He has previously worked in both therapeutics and biology-software companies, and has invested as a VC investor across the UK, EU and US into start-ups and spinouts spanning life-sciences tools, diagnostics, therapeutics and deep technology. He earned a DPhil in Chemical Biology from Oxford and has been involved in the entrepreneurial community there for over 10 years.